Depin Retard

Product Overview:

Depin Retard is a pharmaceutical formulation containing Nifedipine as its active component. This carefully engineered medication delivers controlled cardiovascular support to enhance heart function and maintain circulatory health.

Uses:

This medication is indicated for the treatment of hypertension (elevated blood pressure) and angina pectoris (cardiac-related chest discomfort). Its mechanism facilitates vascular relaxation, enhancing circulation while decreasing cardiac workload.

How to Use:

Administer Depin Retard precisely as prescribed by your medical practitioner. The sustained-release formulation is typically taken once daily, with or without meals. Tablets must be swallowed intact – crushing or chewing alters the controlled-release properties.

Mechanism of Action:

As a calcium channel blocker, Nifedipine prevents calcium ion entry into vascular smooth muscle and cardiac cells. This pharmacological action induces vasodilation, lowers systemic vascular resistance, and decreases myocardial oxygen demand – collectively reducing blood pressure and alleviating anginal symptoms.

Dosage and Administration:

Dosage regimens are customized according to individual therapeutic requirements and clinical response. Strict adherence to prescribed dosing schedules is essential. Healthcare providers should conduct periodic evaluations to assess treatment efficacy and safety parameters.

Therapeutic Benefits:

Clinical advantages include sustained antihypertensive effects, symptomatic relief from angina, and comprehensive cardiovascular protection. The modified-release formulation ensures consistent plasma concentrations for 24-hour therapeutic coverage.

Adverse Effects:

Common adverse reactions may involve cephalgia, peripheral edema, and facial flushing. Persistent or severe manifestations warrant immediate medical consultation. Most side effects are dose-dependent and often transient.

Precautions:

Special consideration is required for patients with comorbid conditions or concurrent pharmacotherapy. Pre-treatment evaluation should include comprehensive medical history review. Ongoing clinical monitoring is recommended to evaluate therapeutic response and detect potential complications.

Storage Conditions:

Maintain product integrity by storing at controlled room temperature (15-30°C) in original packaging. Protect from humidity and light exposure. Implement appropriate safety measures to prevent accidental ingestion by children or animals.

Medical Disclaimer:

The provided information represents current medical knowledge and has undergone professional review. However, this content serves educational purposes only and does not substitute for personalized medical advice. Healthcare providers should be consulted for diagnosis, treatment decisions, and comprehensive risk-benefit assessments. This material may not encompass all potential adverse effects, contraindications, or drug interactions. The intention is to facilitate informed patient-provider discussions, not to replace professional medical judgment.